Objective-To measure the safety and efficacy of antenatal treatment with anti-D immunoglobulin.
Introduction
Routine administration of anti-D immunoglobulin after delivery or abortion will prevent only 90-95% of cases of Rh sensitisation even if there are no failures of organisation.' 2 New cases continue to occur mainly because of sensitisation during pregnancy, which renders prophylaxis after delivery impotent.34 Several workers have shown that giving anti-D immunoglobulin antenatally will prevent many of these cases.3 6 Antenatal prophylaxis, however, has been criticised on the grounds that it is not cost effective7'9; that the risk to donors providing the extra plasma for anti-D immunoglobulin, who require immunisation and boosting by the injection of foreign cells positive for Rh(D), is unacceptably high in the light of the possible benefits7 8; and that its safety to the mother and the fetus has not been adequately shown. '0 The economic argument has been answered by a study in Canada," and, although the risk to donors, particularly of infection with transmitted viruses, remains, careful selection of red cells for injection and modern techniques of testing have reduced the chances of complications to almost nil. There remains the risk to the mother and fetus. Hensleigh has persistently criticised antenatal prophylaxis on this ground' '2 and commented that although Bowman 12 hours apart, and whether the patient had proteinuria >0 25 g/l. When we reviewed the data the criteria for perinatal and obstetric complications, apart from hypertensive complications, varied so much that we included in the analysis only the objective outcomes of survival, birth weight, gestational age at delivery, maternal blood pressure, and proteinuria.
Standard serological techniques were used for grouping and antibody testing as detailed elsewhere.6
Results Table I shows the serological outcome. The number of mothers sensitised was significantly reduced if they had received antenatal prophylaxis rather than postnatal prophylaxis. This was particularly so in the second pregnancy.
The groups were well matched for hospital of delivery and maternal age at first delivery. There was a comparable spread of cases from 17 hospitals. The maximum proportion of cases from any one hospital was 13-8% and the minimum 0-6%; in each group the mean age was comparable. There were minor differences in the years in which the women were first delivered (table II) .
The number (and percentage of valid cases) of first pregnancies delivered before 37 weeks was 26 (4 3%) in group 1, 19 (3 6%) in group 2, and 13 (3 2%) in group 3. In the second pregnancy the numbers of abortions before 12 weeks were 37 (6-3%), 10 (2 0%), and 29 (7 5%), respectively: of abortions from 12 to 28 weeks six (1I0%), 13 (2 6%), and 13 (3 3%), respectively; and of deliveries before 37 weeks 24 (4-1%), 23 (4 6%), and 22 (5 7%), respectively. The mean birth weights in the first pregnancy were 3270 g, 3265 g, and 3190 g and in the second pregnancy 3365 g, 3335 g, and 3305 g. The numbers of babies weighing under 2500 g in the first pregnancy were 22 (3 7%), 28 (5 3%), and 35 (8 6%) and in the second 20 (3-8%), 21 (4 7%), and 23 (6-8%). The numbers of perinatal deaths in the first pregnancy were two, six, and two and in the second three, five, and one. None of the differences between the groups were significant, and, although there were too few deaths for meaningful analysis, no excess was seen in the study group.
The incidences of hypertension and proteinuria were lower in the group given antenatal anti-D, but again the differences did not reach significance (table  III) .
Discussion
The data in table I confirm that antenatal prophylaxis decreased the incidence of maternal sensitisation in mothers entered into the Yorkshire trial.6 In the original report antenatal prophylaxis was reported to have failed in two mothers in their first pregnancy. At delivery they had antibody concentrations of 2 and 4 IU respectively. A further 282 mothers had antibody concentrations below 0 5 IU; the aintibodies were detectable only by enzymes and were judged to be passive antibodies from the previous injection at 34 weeks. Two of these mothers had persistent un- We tried to explore further the safety of antenatal prophylaxis. Among the 1640 mothers who had at least one further pregnancy (889 plus 751, table I) we were able to follow up clinically 1152 (616 in group 1 and 536 group 2, 70%). All the information suggested that the cases were representative, and there was no evidence of different obstetric care. Our results showed no evidence that antenatal prophylaxis was detrimental to either mother or infant. In particular, we cannot support the findings of Tabsch et al of a trend towards increased perinatal mortality and morbidity in infants whose mothers received anti-D immunoglobulin in the second trimester after amniocentesis. 4 This discrepancy may well be due to our antenatal prophylaxis being given later in pregnancy or the selection of mothers requiring amniocentesis. Bowman When studying a treatment regimen for any side effects it is important to avoid the bias created by considering only untoward consequences. Unexpected benefits are also possible, and we paid particular attention to any effects anti-D immunoglobulin may have had on the incidence of hypertensive disease such as pre-eclampsia. Some evidence suggests that previous blood transfusions may reduce the incidence,5 and possibly some blood products also do so.
The data collected, however, though not contradicting this hypothesis, showed no significant difference.
Introduction
Showing a direct relation between damp housing and ill health is by no means straightforward. Firstly, those living in the worst housing conditions are likely to be experiencing other forms of adversity, such as low income and unemployment. Secondly, personal behaviour may also play a part in the causation of ill health. An equally important methodological concern is the process of the data collection itself. If information about health and housing conditions is elicited in the same interview respondents may exaggerate the prevalence of problems, leading to a spurious association between the two phenomena. Moreover, the researchers themselves may influence reporting.
In 1986 we carried out a preliminary study in Edinburgh, which attempted to overcome these methodological difficulties by using a double blind research design.' Children living in damp houses, particularly where there was also mould growth, were reported to have higher rates of respiratory and gastrointestinal symptoms, aches and pains, and fever than children in dry dwellings. These differences could not be attributed to smoking or differences between damp and dry households regarding unemployment, income, overcrowding, or duration of tenancy. The numbers of households that included a child was not large enough (n= 101), however, to permit a full analysis of the role of other possible confounding variables. Accordingly, we carried out a larger scale, more detailed investigation.
Subjects and methods
The study was conducted in three major cities: Edinburgh, Glasgow, and London. Within each city discrete geographical areas of public housing were BMJ VOLUME 298 24 JUNE 1989
